In 2020, the pharmaceutical industry salary rate announced, do you raise wages?

"Pharmaceutical Network Industry Dynamics" it is understood that in the first half of 2020, in the face of the sudden outbreak, many industries have been hit to varying degrees, but there are some industries during the outbreak against the trend of growthrecently, the compensation analysis platform has released a new market compensation white paper for the first half of 2020pay sample covers the Internet, finance, real estate, medicine, consumer goods, education, manufacturing and media eight industriesreported that many companies did not raise wages in the first half of this year because of the outbreak, but unlike most industries, the medical and pharmaceutical industry bucked the trend during the outbreak, rising from 8.63 percent of Q1 to 13.26 percent of Q2according to industry analysis, this is mainly due to two reasons: on the one hand, there is a huge demand for medical devices, such as disposable masks, gloves, etc., on the other hand, people's demand for drugs are not affected by the outbreak, especially in the field of chronic disease drugsit is worth noting that the medical and pharmaceutical industry in the overall pay rate of rising circumstances, different pharmaceutical sub-sectors, the rate of increase is also different, biopharmaceuticals, medical consulting, medical devices to maintain a rate of 10% or so, the industry grew rapidlygenerally speaking, high research and development and high pay are common features of many high-tech and innovative companies, who are more generous to their employees, so the pay rise rate is relatively high, such as Baiji Shenzhou last year's annual report, the group generated a total compensation cost of $262.7 million (RMB1.77 billion), of which O'Reilly and Wu Xiaobin's compensation accounted for only 18.8 per cent of the total compensation costs, so their employees as a whole are paid a higher level and have a certain equity incentiveof course, the pharmaceutical industry, in addition to the increase in various areas of pay, according to the report of medical devices and pharmaceutical sales representatives of the annual fixed pay also variesfor pharmaceutical sales representatives, the average annual fixed salary is 47951, the average annual total cash income is 95059, the median annual fixed salary is 45687, and the median annual total cash income is 91492and medical device sales representatives, due to the high eras of business development, the salary level is higher than that of medical representativesits annual fixed salary average was 74561 and its total annual cash income was 110619but in general, the pay of the pharmaceutical representative is actually lower than the base salary and income of the regional director, sales manager and investment managerand because the high level of medical representatives' pay and the average difference is not much, the job salary increase is not large, the salary ceiling is low;industry believes that pharmaceutical representatives in order to promote and raise wages only to constantly strengthen their own career planning, professional accumulation and their own evolution, to meet the functional needs of the post, in order to have a greater space for personal and salary increases, however, although the pharmaceutical representative is one of the more basic positions in the pharmaceutical industry, because medicine is a special commodity, compared with other industry sales positions, the medical representative is more required to serve in the field of professionalisma good high-paying medical representative, whose professionalism to a certain extent will be no less than the drug research expertsof course, it takes a long time of hard work and self-improvement before it can be achieved.